Literature DB >> 23388717

Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system.

R Alonso Arias1, M A Moro-García, A Echeverría, J J Solano-Jaurrieta, F M Suárez-García, C López-Larrea.   

Abstract

Cytomegalovirus (CMV) infection exerts an enormous effect on human immunity, as it is associated with an immune-impaired response, a variety of chronic diseases, and overall survival in elderly individuals. Levels of anti-CMV antibodies may be associated with the differentiation degree of T cell subsets. Titers are significantly higher in the elderly and positively correlated with specific CD4(+) T cell responses to CMV. In the elderly, antibody titers are associated with the degree of differentiation and the T cell receptor excision circle (TREC) content in CD4(+) T cells, with other features of the immune risk profile, and with a reduced ability to respond to immunization in vivo. Associations may be absent in young subjects because their anti-CMV antibody titers are lower than those of the elderly. However, comparing young and elderly individuals with similar antibody levels reveals differences in their highly differentiated and naïve T cells. These are more marked in individuals with high titers. In parallel with the increase in anti-CMV antibodies, the elderly experience a significant reduction in absolute counts of naïve CD4(+) T cells, which may be a strategy to compensate for the expansion of differentiated cells and to avoid an increase in total T cells. In summary, our results show that titers of anti-CMV antibodies, and not only CMV seropositivity, are related to differentiation status and immunocompetence in the elderly, making this as an important prognostic marker of the status of immune system function.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388717      PMCID: PMC3624366          DOI: 10.1128/JVI.02425-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study.

Authors:  Anders Wikby; Boo Johansson; Jadwiga Olsson; Sture Löfgren; Bengt Olof Nilsson; Frederick Ferguson
Journal:  Exp Gerontol       Date:  2002 Jan-Mar       Impact factor: 4.032

Review 3.  T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation.

Authors:  M D Hazenberg; M C Verschuren; D Hamann; F Miedema; J J van Dongen
Journal:  J Mol Med (Berl)       Date:  2001-11       Impact factor: 4.599

4.  Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study.

Authors:  J Olsson; A Wikby; B Johansson; S Löfgren; B O Nilsson; F G Ferguson
Journal:  Mech Ageing Dev       Date:  2000-12-20       Impact factor: 5.432

5.  Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines.

Authors:  Maria Saurwein-Teissl; Thomas L Lung; Florentine Marx; Claudio Gschösser; Esther Asch; Imrich Blasko; Walther Parson; Günther Böck; Diether Schönitzer; Emanuelle Trannoy; Beatrix Grubeck-Loebenstein
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

6.  Relationship between functional ability in older people, immune system status, and intensity of response to CMV.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Antonio López-Vázquez; Francisco Manuel Suárez-García; Juan José Solano-Jaurrieta; José Baltar; Carlos López-Larrea
Journal:  Age (Dordr)       Date:  2011-04-13

7.  A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation.

Authors:  S Prösch; C E Wendt; P Reinke; C Priemer; M Oppert; D H Krüger; H D Volk; W D Döcke
Journal:  Virology       Date:  2000-07-05       Impact factor: 3.616

8.  Identification of a human recent thymic emigrant phenotype.

Authors:  R D McFarland; D C Douek; R A Koup; L J Picker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

9.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer.

Authors:  Lualhati Harkins; Andrea L Volk; Minu Samanta; Ivan Mikolaenko; William J Britt; Kirby I Bland; Charles S Cobbs
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

10.  Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine.

Authors:  Insoo Kang; Myung Sun Hong; Helena Nolasco; Sung Hwan Park; Jin Myung Dan; Jin-Young Choi; Joe Craft
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  29 in total

Review 1.  Is HIV a model of accelerated or accentuated aging?

Authors:  Sophia Pathai; Hendren Bajillan; Alan L Landay; Kevin P High
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

2.  Age-Related Differences in T-Cell Subsets in a Nationally Representative Sample of People Older Than Age 55: Findings From the Health and Retirement Study.

Authors:  Bharat Thyagarajan; Jessica Faul; Sithara Vivek; Jung K Kim; Janko Nikolich-Žugich; David Weir; Eileen M Crimmins
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-05-05       Impact factor: 6.591

Review 3.  Astrocyte elevated gene-1 (AEG-1) and the A(E)Ging HIV/AIDS-HAND.

Authors:  Neha Vartak-Sharma; Shruthi Nooka; Anuja Ghorpade
Journal:  Prog Neurobiol       Date:  2016-04-14       Impact factor: 11.685

4.  Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults.

Authors:  James E Turner; John P Campbell; Kate M Edwards; Lauren J Howarth; Graham Pawelec; Sarah Aldred; Paul Moss; Mark T Drayson; Victoria E Burns; Jos A Bosch
Journal:  Age (Dordr)       Date:  2013-07-12

5.  Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Authors:  Matthew S Miller; Thomas J Gardner; Florian Krammer; Lauren C Aguado; Domenico Tortorella; Christopher F Basler; Peter Palese
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

Review 6.  Aging and Options to Halt Declining Immunity to Virus Infections.

Authors:  Miguel Ángel Palacios-Pedrero; Albert D M E Osterhaus; Tanja Becker; Husni Elbahesh; Guus F Rimmelzwaan; Giulietta Saletti
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

7.  Anti-CMV-IgG positivity of donors is beneficial for alloHSCT recipients with respect to the better short-term immunological recovery and high level of CD4+CD25high lymphocytes.

Authors:  Emilia Jaskula; Dorota Dlubek; Agnieszka Tarnowska; Janusz Lange; Monika Mordak-Domagala; Krzysztof Suchnicki; Mariola Sedzimirska; Agata Borowik; Sylwia Mizia; Andrzej Lange
Journal:  Viruses       Date:  2015-03-23       Impact factor: 5.048

8.  Decreased proportion of cytomegalovirus specific CD8 T-cells but no signs of general immunosenescence in Alzheimer's disease.

Authors:  Gabriel Westman; Anna-Karin Lidehall; Peetra Magnusson; Martin Ingelsson; Lena Kilander; Lars Lannfelt; Olle Korsgren; Britt-Marie Eriksson
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

9.  When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Carlos López-Larrea
Journal:  Front Immunol       Date:  2013-05-10       Impact factor: 7.561

10.  Molecular mechanisms associated with the strength of the anti-CMV response in nonagenarians.

Authors:  Saara Marttila; Juulia Jylhävä; Laura Kananen; Antti Hervonen; Marja Jylhä; Mikko Hurme
Journal:  Immun Ageing       Date:  2014-01-31       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.